Navigation Links
PGI To Invest in Nonwovens Technology in U.S. and Asia to Serve Hygiene and Healthcare Markets
Date:12/21/2009

CHARLOTTE, N.C., Dec. 21 /PRNewswire-FirstCall/ -- Polymer Group, Inc. (OTC Bulletin Board: POLGA; POLGB) (PGI) announced today it is investing in industry-leading technology in both the U.S. and Asia to serve the hygiene and healthcare marketplace.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080903/CLW036LOGO-b )

PGI plans to install new state-of-the-art, custom-designed, spunmelt machines in the U.S. and China. Construction associated with the projects is expected to begin early in the first quarter of 2010 and material is expected to be commercially available in mid-2011.

With the expansion, PGI will employ industry-leading technologies, combined with recent proprietary technological developments, to deliver differentiated products to customers that will achieve improved barrier, softness and opacity versus current marketplace capabilities for use in such products as diapers, and surgical gowns and drapes.

"This expansion in product capability and capacity is part of PGI's ongoing strategy to provide superior solutions to the marketplace and meet customers' stated needs for higher performing products with an optimum combination of barrier and comfort," said Veronica "Ronee" Hagen, chief executive officer of PGI.

The latest expansion is part of PGI's continuing strategy to optimize its global footprint, following investments by the company in Mexico and Europe in 2009.

"PGI's ongoing investment in global research and development has led to substantial product differentiation and innovation," said Mike Hale, PGI's chief operating officer. "Combined with our best-in-class converting performance, service, professional sales and technical support, PGI provides customers with the support they need to drive solutions for today, as well as for the long term."

Polymer Group, Inc., one of the world's leading producers of nonwovens, is a global, technology-driven developer, producer and marketer of engineered materials. With the broadest range of process technologies in the nonwovens industry, PGI is a global supplier to leading consumer and industrial product manufacturers. The company operates 15 manufacturing and converting facilities in nine countries throughout the world.

Safe Harbor Statement

Except for historical information contained herein, the matters set forth in this press release are forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that involve certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These forwardlooking statements speak only as of the date of this release. Important factors that could cause actual results to differ materially from those discussed in such forwardlooking statements include: general economic factors including, but not limited to, changes in interest rates, foreign currency translation rates, consumer confidence, trends in disposable income, changes in consumer demand for goods produced, and cyclical or other downturns; cost and availability of raw materials, labor and natural and other resources and the inability to pass raw material cost increases along to customers; changes to selling prices to customers which are based, by contract, on an underlying raw material index; substantial debt levels and potential inability to maintain sufficient liquidity to finance our operations and make necessary capital expenditures; inability to meet existing debt covenants; achievement of objectives for strategic acquisitions and dispositions; inability to achieve successful or timely start-up on new or modified production lines; reliance on major customers and suppliers; domestic and foreign competition; information and technological advances; risks related to operations in foreign jurisdictions; and changes in environmental laws and regulations. Investors and other readers are directed to consider the risks and uncertainties discussed in documents filed by Polymer Group, Inc. with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.


    For media inquiries, please contact:
    Cliff Bridges
    Global Marketing and HR Communications Director
    (704) 697-5168
    bridgesc@pginw.com

    For investor inquiries, please contact:
    Dennis Norman
    Chief Financial Officer
    (704) 697-5186
    normand@pginw.com

SOURCE Polymer Group, Inc.


'/>"/>
SOURCE Polymer Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Pacific to Release Financial Results and Hold Fiscal 2009 Year-End and Fourth Quarter Investor Teleconference
2. Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study
3. Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015
4. VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled
5. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
6. $12 Million American Recovery and Reinvestment Act Grant Awarded to Urban Health Plan, Inc. (UHP)
7. BHR Pharma Files Investigational New Drug Application, Receives Orphan Drug Designation, for Traumatic Brain Injury Treatment
8. FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters
9. Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease
10. Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share
11. BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors Informational and Educational Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: